SanBio Company Limited (TYO:4592)
Japan · Delayed Price · Currency is JPY 950.00
-21.00 (-2.16%)
Aug 6, 2026, 11:30 AM JST
SanBio Company Cash Flow Statement
Financials in millions JPY. Fiscal year is February - January.
Millions JPY. Fiscal year is Feb - Jan.
Operating Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jan '26 Jan 31, 2026 | Jan '25 Jan 31, 2025 | Jan '24 Jan 31, 2024 | Jan '23 Jan 31, 2023 | Jan '22 Jan 31, 2022 |
Net Income | -4,291 | -3,010 | -2,542 | -4,697 | -4,560 |
Depreciation & Amortization | 8 | 9 | 14 | 24 | 132 |
Loss (Gain) From Sale of Assets | - | -2 | -30 | -1 | 10 |
Other Operating Activities | 34 | -18 | -1 | -90 | -186 |
Change in Inventory | - | - | - | 510 | 3 |
Change in Accounts Payable | -65 | -172 | -93 | -241 | 78 |
Change in Other Net Operating Assets | 554 | -410 | -2,113 | -2,939 | -2,023 |
Operating Cash Flow | -3,760 | -3,603 | -4,765 | -7,434 | -6,546 |
Operating Cash Flow Growth | - | - | - | - | - |
Investing Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jan '26 Jan 31, 2026 | Jan '25 Jan 31, 2025 | Jan '24 Jan 31, 2024 | Jan '23 Jan 31, 2023 | Jan '22 Jan 31, 2022 |
Capital Expenditures | -32 | -4 | -11 | -7 | -42 |
Sale of Property, Plant & Equipment | 1 | - | 35 | 1 | - |
Sale (Purchase) of Intangibles | - | - | -43 | - | -14 |
Investment in Securities | -200 | - | - | - | - |
Other Investing Activities | - | - | - | -4 | -10 |
Investing Cash Flow | -231 | -4 | -19 | -10 | -66 |
Financing Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jan '26 Jan 31, 2026 | Jan '25 Jan 31, 2025 | Jan '24 Jan 31, 2024 | Jan '23 Jan 31, 2023 | Jan '22 Jan 31, 2022 |
Long-Term Debt Issued | 1,080 | - | - | - | - |
Total Debt Issued | 1,080 | - | - | - | - |
Short-Term Debt Repaid | - | - | - | - | -500 |
Long-Term Debt Repaid | -268 | -268 | -268 | -1,592 | -975 |
Total Debt Repaid | -268 | -268 | -268 | -1,592 | -1,475 |
Net Debt Issued (Repaid) | 812 | -268 | -268 | -1,592 | -1,475 |
Issuance of Common Stock | 15,195 | 2,372 | 2,651 | 11,055 | 3 |
Other Financing Activities | -45 | -13 | -13 | -18 | -23 |
Financing Cash Flow | 15,962 | 2,091 | 2,370 | 9,445 | -1,495 |
Net Cash Flow
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jan '26 Jan 31, 2026 | Jan '25 Jan 31, 2025 | Jan '24 Jan 31, 2024 | Jan '23 Jan 31, 2023 | Jan '22 Jan 31, 2022 |
Foreign Exchange Rate Adjustments | -8 | -20 | 128 | 116 | 185 |
Miscellaneous Cash Flow Adjustments | -1 | - | 1 | 1 | -1 |
Net Cash Flow | 11,962 | -1,536 | -2,285 | 2,118 | -7,923 |
Free Cash Flow
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jan '26 Jan 31, 2026 | Jan '25 Jan 31, 2025 | Jan '24 Jan 31, 2024 | Jan '23 Jan 31, 2023 | Jan '22 Jan 31, 2022 |
Free Cash Flow | -3,792 | -3,607 | -4,776 | -7,441 | -6,588 |
Free Cash Flow Growth | - | - | - | - | - |
Free Cash Flow Per Share | -51.86 | -52.38 | -73.11 | -128.47 | -127.21 |
Levered Free Cash Flow | -2,469 | -2,302 | -3,316 | -4,506 | -4,274 |
Unlevered Free Cash Flow | -2,446 | -2,297 | -3,310 | -4,490 | -4,247 |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jan '26 Jan 31, 2026 | Jan '25 Jan 31, 2025 | Jan '24 Jan 31, 2024 | Jan '23 Jan 31, 2023 | Jan '22 Jan 31, 2022 |
Cash Interest Paid | 5 | 8 | 10 | 25 | 45 |
Cash Income Tax Paid | -3 | 16 | - | 89 | 187 |
Change in Working Capital | 489 | -582 | -2,206 | -2,670 | -1,942 |